Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Venter

Showing results (91-100 of 248) with videos related to

Pageof 25
Sort By:
Nature Medicine|December 10, 1998
From genomics to vaccines: malaria as a model systemS L Hoffman, W O Rogers, D J Carucci, et al.
Biochemical and Biophysical Research Communications|October 14, 1988
Discrepancies between the affinities of binding and action of the novel beta-adrenergic agonist BRL 37344 in rat brown adipose tissueP Muzzin, J Seydoux, J P Giacobino, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1972
Biologically active catecholamines covalentyly bound to glass beadsJ C Venter, J E Dixon, P R Maroko, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The small-intestinal sodium-glucose cotransporter(s)G Semenza, M Kessler, U Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclaseC M Fraser, F Z Chung, C D Wang, et al.
The Biochemical Journal|April 15, 1986
Target size of the adenosine Ri receptorL T Frame, S M Yeung, J C Venter, et al.
The American Review of Respiratory Disease|September 1, 1984
Monoclonal antibodies to surface antigens of rabbit type II pneumocytesC M Fraser, J C Venter, J N Finkelstein, et al.
Biochemical Medicine|January 1, 1975
A possible role for glass bead immobilized enzymes as therapeutic agents (immobilized uricase as enzyme therapy for hyperuricemia)J C Venter, B R Venter, J E Dixon, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 2, 1988
In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin)P L Botha, C J van Heerden, E Vorster, et al.
Nephron|January 1, 1980
Taste, smell and zinc metabolism in patients with chronic renal failureH J Vreman, C Venter, J Leegwater, et al.
Pageof 25

Showing results (91-100 of 248) with videos related to

Sort By:
Pageof 25
Nature Medicine|December 10, 1998
From genomics to vaccines: malaria as a model systemS L Hoffman, W O Rogers, D J Carucci, et al.
Biochemical and Biophysical Research Communications|October 14, 1988
Discrepancies between the affinities of binding and action of the novel beta-adrenergic agonist BRL 37344 in rat brown adipose tissueP Muzzin, J Seydoux, J P Giacobino, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1972
Biologically active catecholamines covalentyly bound to glass beadsJ C Venter, J E Dixon, P R Maroko, et al.
Annals of the New York Academy of Sciences|January 1, 1985
The small-intestinal sodium-glucose cotransporter(s)G Semenza, M Kessler, U Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclaseC M Fraser, F Z Chung, C D Wang, et al.
The Biochemical Journal|April 15, 1986
Target size of the adenosine Ri receptorL T Frame, S M Yeung, J C Venter, et al.
The American Review of Respiratory Disease|September 1, 1984
Monoclonal antibodies to surface antigens of rabbit type II pneumocytesC M Fraser, J C Venter, J N Finkelstein, et al.
Biochemical Medicine|January 1, 1975
A possible role for glass bead immobilized enzymes as therapeutic agents (immobilized uricase as enzyme therapy for hyperuricemia)J C Venter, B R Venter, J E Dixon, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 2, 1988
In vitro evaluation of the cyclic lipopeptide LY 146032 (daptomycin)P L Botha, C J van Heerden, E Vorster, et al.
Nephron|January 1, 1980
Taste, smell and zinc metabolism in patients with chronic renal failureH J Vreman, C Venter, J Leegwater, et al.
Pageof 25